2892. Safety and Immunogenicity of mRNA-1647, an mRNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results of a Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Finding Trial

BACKGROUND: A safe and effective method to protect against cytomegalovirus (CMV) infection is a public health priority. mRNA-1647 is an investigational mRNA-based vaccine against CMV consisting of 6 mRNA sequences encoding 2 CMV antigens (glycoprotein B and the pentameric glycoprotein complex) in li...

Descripción completa

Detalles Bibliográficos
Autores principales: Panther, Lori, Basnet, Sandeep, Fierro, Carlos, Brune, Daniel, Leggett, Richard, Peterson, James, Pickrell, Paul, Lin, Jiang, Wu, Kai, Lee, Heather, Hasselbeck, Roxane, Natenshon, Andrew, Miller, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677300/
http://dx.doi.org/10.1093/ofid/ofad500.2475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677300/
http://dx.doi.org/10.1093/ofid/ofad500.2475

Ejemplares similares